[Federal Register Volume 61, Number 32 (Thursday, February 15, 1996)]
[Notices]
[Page 6045]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-3402]



-----------------------------------------------------------------------


NUCLEAR REGULATORY COMMISSION

Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene its next 
regular meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on February 21-22, 1996. The meeting was noticed in 
the Federal Register on January 26, 1996. In addition to the discussion 
of the National Academy of Science's, Institute of Medicine report, the 
staff will discuss two additional issues. The first issue is a proposed 
rule requiring licensees to notify the NRC Operations Center within 24 
hours of discovering an intentional or allegedly intentional diversion 
of licensed radioactive material from its intended or authorized use. 
The proposed rule would also require licensees to notify NRC when they 
are unable, within 48 hours of discovery of the event, to rule out that 
the use was intentional. The proposed rule would require reporting of 
events that cause, or have the potential to cause, an exposure of 
individuals whether or not the exposure exceeds the regulatory limits. 
The comment period for this rule closes March 1, 1996. The second issue 
is the lessons learned and action items resulting from the Augmented 
Inspection Team and Incident Investigation Team reviews of internal 
contamination events at the National Institutes of Health and 
Massachusetts Institute of Technology, respectively. These issues were 
added as agenda items at the request of the ACMUI Chairman. Because of 
the 30 day comment period, the February meeting is the only opportunity 
for ACMUI to discuss the proposed rule in a public meeting within the 
specified comment period.
    The meeting will take place at the address provided below. All 
sessions of the meeting will be open to the public.

DATES: The meeting will begin at 8:30 a.m., on February 21 and 22, 
1996.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION, CONTACT: Josephine M. Piccone, Ph.D., U.S. 
Nuclear Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards, MS T8F5, Washington, DC 20555, telephone (301) 415-7270. 
For administrative information, contact Torre Taylor, telephone (301) 
415-7900.

Conduct of the Meeting

    Barry Siegel, M.D., will chair and conduct the meeting in a manner 
that will facilitate the orderly conduct of business. The following 
procedures apply to public participation in the meeting:

    1. Persons who wish to provide a written statement should submit 
a reproducible copy to Josephine M. Piccone (address listed 
previously), by February 16, 1996. The transcript of the meeting 
will be kept open until February 26, 1996, for inclusion of written 
comments submitted after February 16, 1996. Statements must pertain 
to the topics on the agenda for the meeting.
    2. At the meeting, questions from members of the public will be 
permitted at the discretion of the Chairman.
    3. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street, NW., Lower Level, Washington, DC 20555, telephone 
(202) 634-3273, on or about March 8, 1996. Minutes of the meeting 
will be available on or about April 5, 1996.
    4. Seating for the public will be on a first-come, first-served 
basis.
    This meeting will be held in accordance with the Atomic Energy 
Act of 1954, as amended (primarily Section 161a); the Federal 
Advisory Committee Act (5 U.S.C. App.); and the Commission's 
regulations in Title 10, U.S. Code of Federal Regulations, Part 7.

    Dated: February 9, 1996.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 96-3402 Filed 2-14-96; 8:45 am]
BILLING CODE 7590-01-P